Literature DB >> 28190295

High prevalence of fatigue in adults with a 22q11.2 deletion syndrome.

Elfi Vergaelen1,2, Stephan Claes2, Stefan Kempke3, Ann Swillen1,4.   

Abstract

The 22q11.2 deletion syndrome (22q11.2DS) is a microdeletion syndrome with high phenotypic variability, including somatic disorders like congenital heart disease and psychiatric disorders such as schizophrenia, anxiety disorders, and mood disorders. Clinical observations suggest that many patients with 22q11.2DS suffer from severe fatigue. However, to the best of our knowledge, no previous study has investigated the potential association between 22q11.2DS and fatigue. Twenty-nine patients (mean age 26.8, 18-38 y) with 22q11.2DS completed the multidimensional fatigue inventory (MFI) measuring severity of fatigue. The results of the study group were compared with published population norms. In addition, cross-sectional associations between fatigue, depression (Beck Depression Inventory-BDI), and a quality of life questionnaire (WHO) in patients with 22q11.2 DS were examined. Subscales and total MFI scores were significantly higher in adults with 22q11.2DS. Approximately 80% of the study group had a total MFI score above the mean of the norms. A significant correlation between depressive symptoms and fatigue was found. Fatigue was also significantly associated with quality of life scores, specifically the general score, psychological health, and environment. This is the first report of high levels of fatigue in adults with the 22q11.2DS. Fatigue is a frequent complaint in this age group and should get the necessary attention given its association with quality of life and depression severity. Taking into account the multisystem nature of the 22q11.2DS, we recommend a systematic clinical examination to exclude underlying somatic or psychiatric causes of fatigue.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  22q11.2 deletion syndrome; beck depression inventory; fatigue; multidimensional fatigue inventory; quality of life

Mesh:

Year:  2017        PMID: 28190295     DOI: 10.1002/ajmg.a.38094

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

Review 1.  22q11.2 Deletion Syndrome-Associated Parkinson's Disease.

Authors:  Erik Boot; Anne S Bassett; Connie Marras
Journal:  Mov Disord Clin Pract       Date:  2018-11-09

2.  Ocular findings in 22q11.2 deletion syndrome: A systematic literature review and results of a Dutch multicenter study.

Authors:  Emma N M M von Scheibler; Emy S van der Valk Bouman; Myrthe A Nuijts; Noël J C Bauer; Tos T J M Berendschot; Pit Vermeltfoort; Levinus A Bok; Agnies M van Eeghen; Michiel L Houben; Thérèse A M J van Amelsvoort; Erik Boot; Michelle B van Egmond-Ebbeling
Journal:  Am J Med Genet A       Date:  2021-11-12       Impact factor: 2.578

Review 3.  Deletion Syndrome 22q11.2: A Systematic Review.

Authors:  Jonathan Cortés-Martín; Nuria López Peñuela; Juan Carlos Sánchez-García; Maria Montiel-Troya; Lourdes Díaz-Rodríguez; Raquel Rodríguez-Blanque
Journal:  Children (Basel)       Date:  2022-08-03

4.  Resilience and quality of life in young adults with a 22q11.2 deletion syndrome: a patient's perspective.

Authors:  Kris Van de Woestyne; Ans Vandensande; Elfi Vergaelen; Ann Swillen; Kristof Vansteelandt; Bea Maes
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-06-11       Impact factor: 4.785

5.  Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.

Authors:  Erik Boot; Nancy J Butcher; Sean Udow; Connie Marras; Kin Y Mok; Satoshi Kaneko; Matthew J Barrett; Paolo Prontera; Brian D Berman; Mario Masellis; Boris Dufournet; Karine Nguyen; Perrine Charles; Eugénie Mutez; Teodor Danaila; Aurélia Jacquette; Olivier Colin; Sophie Drapier; Michel Borg; Ania M Fiksinski; Elfi Vergaelen; Ann Swillen; Annick Vogels; Annika Plate; Claudia Perandones; Thomas Gasser; Kristien Clerinx; Frédéric Bourdain; Kelly Mills; Nigel M Williams; Nicholas W Wood; Jan Booij; Anthony E Lang; Anne S Bassett
Journal:  Neurology       Date:  2018-05-11       Impact factor: 9.910

6.  Comprehensive analysis of a novel mouse model of the 22q11.2 deletion syndrome: a model with the most common 3.0-Mb deletion at the human 22q11.2 locus.

Authors:  Ryo Saito; Michinori Koebis; Taku Nagai; Kimiko Shimizu; Jingzhu Liao; Bolati Wulaer; Yuki Sugaya; Kenichiro Nagahama; Naofumi Uesaka; Itaru Kushima; Daisuke Mori; Kazuaki Maruyama; Kazuki Nakao; Hiroki Kurihara; Kiyofumi Yamada; Masanobu Kano; Yoshitaka Fukada; Norio Ozaki; Atsu Aiba
Journal:  Transl Psychiatry       Date:  2020-02-05       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.